BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

29583

524654

NATCAPSUQ

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

NATURAL CAPSULES LIMITED performance

Today’s low

Today’s high

₹ 195.00 ₹ 210.99
₹ 200.68

52 week low

52 week high

₹ 164.00 ₹ 269.80
₹ 200.68

Open Price

₹ 200.00

Prev. Close

₹ 200.83

Volume (Shares)

3193.00

Total traded value

₹ 6.40

Upper Circuit

₹ 240.99

Lower Circuit

₹ 160.66

info

NATURAL CAPSULES LIMITED Share Price Update

As of the latest trading session, NATURAL CAPSULES LIMITED share price is currently at ₹ 201, which is up by ₹ 0.16 from its previous closing. Today, the stock has fluctuated between ₹ 195.00 and ₹ 210.99. Over the past year, NATURAL CAPSULES LIMITED has achieved a return of 0.00 %. In the last month alone, the return has been 5.78 %. Read More...

NATURAL CAPSULES LIMITED fundamentals


  • Market cap (Cr)

    187.91

  • P/E Ratio (TTM)

    36.17

  • Beta

    0.45

  • Book Value / share

    158.46

  • Return on equity

    6.10%

  • EPS (TTM)

    5.58

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    1.70

info icon alternate text
  • Market cap (Cr)

    191.46

  • P/E Ratio (TTM)

    36.17

  • Beta

    0.51

  • Book Value / share

    158.46

  • Return on equity

    6.10%

  • EPS (TTM)

    5.58

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    1.70

info icon alternate text

NATURAL CAPSULES LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 43.41
Operating Expense 42.35
Net Profit 1.70
Net Profit Margin (%) 3.91
Earnings Per Share (EPS) 1.65
EBITDA 5.74
Effective Tax Rate (%) 23.07
Particulars SEP 2024 (Values in Cr)
Revenue 41.03
Operating Expense 39.78
Net Profit 0.92
Net Profit Margin (%) 2.24
Earnings Per Share (EPS) 0.90
EBITDA 5.71
Effective Tax Rate (%) 54.22
Particulars JUN 2024 (Values in Cr)
Revenue 39.14
Operating Expense 37.97
Net Profit 1.46
Net Profit Margin (%) 3.73
Earnings Per Share (EPS) 1.56
EBITDA 5.49
Effective Tax Rate (%) 24.74
Particulars MAR 2024 (Values in Cr)
Revenue 40.20
Operating Expense 39.22
Net Profit 1.69
Net Profit Margin (%) 4.20
Earnings Per Share (EPS) 2.09
EBITDA 5.76
Effective Tax Rate (%) 24.55
Particulars DEC 2023 (Values in Cr)
Revenue 38.38
Operating Expense 36.80
Net Profit 1.70
Net Profit Margin (%) 4.42
Earnings Per Share (EPS) 1.82
EBITDA 5.65
Effective Tax Rate (%) 25.76
Particulars MAR 2024 (Values in Cr)
Revenue 153.81
Operating Expense 146.56
Net Profit 7.81
Net Profit Margin (%) 5.07
Earnings Per Share (EPS) 8.64
EBITDA 23.91
Effective Tax Rate (%) 24.92
Particulars MAR 2023 (Values in Cr)
Revenue 172.87
Operating Expense 148.20
Net Profit 19.20
Net Profit Margin (%) 11.10
Earnings Per Share (EPS) 20.63
EBITDA 36.50
Effective Tax Rate (%) 25.40
Particulars MAR 2022 (Values in Cr)
Revenue 135.07
Operating Expense 116.57
Net Profit 13.95
Net Profit Margin (%) 10.32
Earnings Per Share (EPS) 19.62
EBITDA 26.43
Effective Tax Rate (%) 28.20
Particulars MAR 2021 (Values in Cr)
Revenue 79.51
Operating Expense 73.23
Net Profit 6.95
Net Profit Margin (%) 8.74
Earnings Per Share (EPS) 7.55
EBITDA 13.86
Effective Tax Rate (%) 24.37
Particulars MAR 2020 (Values in Cr)
Revenue 61.55
Operating Expense 61.13
Net Profit 0.86
Net Profit Margin (%) 1.39
Earnings Per Share (EPS) 1.41
EBITDA 6.26
Effective Tax Rate (%) 37.22
Particulars MAR 2024 (Values in Cr)
Book Value / Share 218.39
ROE % 3.39
ROCE % 5.00
Total Debt to Total Equity 0.63
EBITDA Margin 14.15
Particulars MAR 2023 (Values in Cr)
Book Value / Share 132.85
ROE % 17.89
ROCE % 16.14
Total Debt to Total Equity 0.73
EBITDA Margin 20.84
Particulars MAR 2022 (Values in Cr)
Book Value / Share 118.34
ROE % 19.18
ROCE % 20.60
Total Debt to Total Equity 0.43
EBITDA Margin 19.63
Particulars MAR 2021 (Values in Cr)
Book Value / Share 99.63
ROE % 8.94
ROCE % 11.16
Total Debt to Total Equity 0.14
EBITDA Margin 14.86
Particulars MAR 2020 (Values in Cr)
Book Value / Share 89.24
ROE % 1.55
ROCE % 3.70
Total Debt to Total Equity 0.11
EBITDA Margin 10.40
Particulars MAR 2024 (Values in Cr)
Book Value / Share 141.30
ROE % 6.10
ROCE % 8.43
Total Debt to Total Equity 0.44
EBITDA Margin 15.64
Particulars MAR 2023 (Values in Cr)
Book Value / Share 133.74
ROE % 18.54
ROCE % 20.43
Total Debt to Total Equity 0.40
EBITDA Margin 21.30
Particulars MAR 2022 (Values in Cr)
Book Value / Share 118.45
ROE % 19.22
ROCE % 22.76
Total Debt to Total Equity 0.30
EBITDA Margin 19.65
Particulars MAR 2021 (Values in Cr)
Book Value / Share 99.68
ROE % 9.00
ROCE % 11.21
Total Debt to Total Equity 0.14
EBITDA Margin 14.90
Particulars MAR 2020 (Values in Cr)
Book Value / Share 89.24
ROE % 1.55
ROCE % 3.70
Total Debt to Total Equity 0.11
EBITDA Margin 10.40
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 13.33
Total Assets 376.52
Total Liabilities 376.52
Total Equity 228.80
Share Outstanding 9349050
Price to Book Ratio 2.16
Return on Assets (%) 1.47
Return on Capital (%) 1.64
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 6.92
Total Assets 288.76
Total Liabilities 288.76
Total Equity 148.24
Share Outstanding 9277500
Price to Book Ratio 2.94
Return on Assets (%) 6.38
Return on Capital (%) 7.54
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 4.88
Total Assets 164.27
Total Liabilities 164.27
Total Equity 82.98
Share Outstanding 7011800
Price to Book Ratio 3.90
Return on Assets (%) 8.46
Return on Capital (%) 10.29
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.73
Total Assets 97.04
Total Liabilities 97.04
Total Equity 62.09
Share Outstanding 6232700
Price to Book Ratio 1.08
Return on Assets (%) 7.12
Return on Capital (%) 9.64
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.92
Total Assets 74.68
Total Liabilities 74.68
Total Equity 55.62
Share Outstanding 6232700
Price to Book Ratio 0.37
Return on Assets (%) 1.14
Return on Capital (%) 1.39
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 9.24
Total Assets 231.26
Total Liabilities 231.26
Total Equity 131.86
Share Outstanding 9321578
Price to Book Ratio 2.16
Return on Assets (%) 3.37
Return on Capital (%) 4.03
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 2.24
Total Assets 210.39
Total Liabilities 210.39
Total Equity 124.05
Share Outstanding 9277500
Price to Book Ratio 2.94
Return on Assets (%) 9.12
Return on Capital (%) 11.08
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.98
Total Assets 143.49
Total Liabilities 143.49
Total Equity 83.05
Share Outstanding 7011800
Price to Book Ratio 3.90
Return on Assets (%) 9.72
Return on Capital (%) 12.05
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.22
Total Assets 96.65
Total Liabilities 96.65
Total Equity 62.13
Share Outstanding 6232700
Price to Book Ratio 1.08
Return on Assets (%) 7.18
Return on Capital (%) 9.68
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.92
Total Assets 74.68
Total Liabilities 74.68
Total Equity 55.62
Share Outstanding 6232700
Price to Book Ratio 0.37
Return on Assets (%) 1.14
Return on Capital (%) 1.39
Particulars MAR 2024 (Values in Cr)
Net Income 8.05
Cash from Operations -6.38
Cash from Investing -72.58
Cash from Financing 81.71
Net change in Cash 0.77
Free Cash Flow 65.24
Particulars MAR 2023 (Values in Cr)
Net Income 24.99
Cash from Operations 22.67
Cash from Investing -104.62
Cash from Financing 87.49
Net change in Cash 0.07
Free Cash Flow 128.56
Particulars MAR 2022 (Values in Cr)
Net Income 19.38
Cash from Operations 4.22
Cash from Investing -45.87
Cash from Financing 47.69
Net change in Cash 1.30
Free Cash Flow 48.55
Particulars MAR 2021 (Values in Cr)
Net Income 9.19
Cash from Operations 8.01
Cash from Investing -8.53
Cash from Financing 2.51
Net change in Cash -0.23
Free Cash Flow 24.43
Particulars MAR 2020 (Values in Cr)
Net Income 1.37
Cash from Operations 7.86
Cash from Investing -5.74
Cash from Financing -1.18
Net change in Cash 0.27
Free Cash Flow 13.16
Particulars MAR 2024 (Values in Cr)
Net Income 10.39
Cash from Operations 7.36
Cash from Investing -10.83
Cash from Financing 7.23
Net change in Cash 1.79
Free Cash Flow 16.19
Particulars MAR 2023 (Values in Cr)
Net Income 25.74
Cash from Operations 25.55
Cash from Investing -55.42
Cash from Financing 34.44
Net change in Cash -0.87
Free Cash Flow 62.77
Particulars MAR 2022 (Values in Cr)
Net Income 19.42
Cash from Operations 9.83
Cash from Investing -30.42
Cash from Financing 26.51
Net change in Cash 1.18
Free Cash Flow 38.63
Particulars MAR 2021 (Values in Cr)
Net Income 9.19
Cash from Operations 8.00
Cash from Investing -8.53
Cash from Financing 2.51
Net change in Cash -0.23
Free Cash Flow 24.42
Particulars MAR 2020 (Values in Cr)
Net Income 1.37
Cash from Operations 7.86
Cash from Investing -5.74
Cash from Financing -1.18
Net change in Cash 0.27
Free Cash Flow 13.16
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 19.60 1.99 279.41 34.11 / 77.70
BLISS GVS PHARMA LTD 119.00 15.60 1.24 1253.91 92.25 / 184.95
CIPLA LTD 1549.65 25.08 4.41 125155.99 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 260.70 21.60 2.64 767.27 145.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 21.96 6.19 279.41 34.11 / 77.70
AMRUTAJAN HEALTH LTD 692.80 40.61 6.72 2002.93 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8665.50 129.24 31.88 21663.75 5000.00 / 9199.00
BLISS GVS PHARMA LTD 119.00 15.45 1.22 1253.91 92.25 / 184.95

NATURAL CAPSULES LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
200.68 -0.07 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 207.70
  • 26 Days 210.90
  • 10 Days 211.70
  • 50 Days 207.70
  • 12 Days 211.90
  • 100 Days 207.70
  • 20 Days 210.80
  • 200 Days 207.70
201.32 PIVOT

First Support

197.13

First Resistance

205.01

Second Support

193.44

Second Resistance

209.20

Third Support

189.25

Third Resistance

212.89

RSI

43.36

ADX

17.81

MACD

0.95

Williams % R

-79.25

Commodity Channel Index (CCI)

-45.26

Date

2025-04-30

Week

2691.00

Same Day

1051.00

Month

4510.00

1 Year

0.45

3 Year

0.46

Over 1 Month

5.78%

down

Over 1 Year

0.00%

down

Over 3 Months

-19.58%

down

Over 3 Years

0.00%

down

Over 6 Months

0.00%

down

Over 5 Years

0.00%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

NATURAL CAPSULES LIMITED shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
48.78%
Promoter Holdings
51.21%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Tajos Investments Private Limited 1253500.0 (12.12%) Shareholding of Promoter and Promoter Group
Nandi Synthetics Pvt Ltd 919354.0 (8.89%) Shareholding of Promoter and Promoter Group
Sunil Laxminaryan Mundra 596790.0 (5.77%) Shareholding of Promoter and Promoter Group
Sushil Kumar Mundra 509012.0 (4.92%) Shareholding of Promoter and Promoter Group
Indra Mundra 391800.0 (3.79%) Shareholding of Promoter and Promoter Group
Tarinika Management Llp 333333.0 (3.22%) Public Shareholding
Sangeetha S 327000.0 (3.16%) Public Shareholding
Jyoti Mundra 306694.0 (2.97%) Shareholding of Promoter and Promoter Group
Sharada Mundra 265036.0 (2.56%) Shareholding of Promoter and Promoter Group
Laxminarayan Moondra 240441.0 (2.33%) Shareholding of Promoter and Promoter Group
Radha S Mundra 239400.0 (2.32%) Shareholding of Promoter and Promoter Group
Satyanarayan Mundra 184882.0 (1.79%) Shareholding of Promoter and Promoter Group
Pcg Finvest Private Ltd 166667.0 (1.61%) Public Shareholding
Shrey Mundra 165150.0 (1.6%) Shareholding of Promoter and Promoter Group
Madhav Mundra 165155.0 (1.6%) Shareholding of Promoter and Promoter Group
Vivog Commercial Limited 149281.0 (1.44%) Public Shareholding
Anurag Singhi 117062.0 (1.13%) Public Shareholding
Jyotsna Daga 37789.0 (0.37%) Shareholding of Promoter and Promoter Group
Nidhi Sethia 18484.0 (0.18%) Shareholding of Promoter and Promoter Group
Chandra Rameshwar Laddha 1000.0 (0.01%) Shareholding of Promoter and Promoter Group
Bhagyalakshmi 200.0 (0.0%) Shareholding of Promoter and Promoter Group
C M Gurumurthy 200.0 (0.0%) Shareholding of Promoter and Promoter Group
Vijay Daulal Damani 361.0 (0.0%) Shareholding of Promoter and Promoter Group
Mukund Gattani 500.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

NATURAL CAPSULES LIMITED corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
20 Jul 2023 1.0 Final 20 Jul 2023 Equity shares
09 Sep 2022 1.0 Final 13 Sep 2022 Equity shares
06 Jul 2021 1.0 Final 08 Jul 2021 Equity shares
12 Aug 2020 0.6 Final 14 Aug 2020 Equity shares
13 Aug 2019 1.0 Final 15 Aug 2019 Equity shares
12 Sep 2018 1.0 Final 15 Sep 2018 Equity shares
18 Aug 2017 1.0 Final 22 Aug 2017 Equity shares
16 Aug 2016 1.5 Final 19 Aug 2016 Equity shares
19 Aug 2015 1.5 Final 21 Aug 2015 Equity shares
20 Aug 2014 1.5 Final 22 Aug 2014 Equity shares
19 Jul 2013 1.5 Final 23 Jul 2013 Equity shares
20 Jul 2012 1.5 Final 24 Jul 2012 Equity shares
21 Jul 2011 1.2 Final 23 Jul 2011 Equity shares
23 Sep 2010 1.2 Final 25 Sep 2010 Equity shares
23 Jul 2009 1.2 Final 27 Jul 2009 Equity shares
24 Jul 2008 1.0 Final 26 Jul 2008 Equity shares
20 Jul 2007 1.0 Final 24 Jul 2007 Equity shares
21 Jul 2005 0.0 Final 23 Jul 2005 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
20 Jul 2023 1.0 Final 20 Jul 2023 Equity shares
09 Sep 2022 1.0 Final 13 Sep 2022 Equity shares
06 Jul 2021 1.0 Final 08 Jul 2021 Equity shares
12 Aug 2020 0.6 Final 14 Aug 2020 Equity shares
13 Aug 2019 1.0 Final 15 Aug 2019 Equity shares
12 Sep 2018 1.0 Final 15 Sep 2018 Equity shares
18 Aug 2017 1.0 Final 22 Aug 2017 Equity shares
16 Aug 2016 1.5 Final 19 Aug 2016 Equity shares
19 Aug 2015 1.5 Final 21 Aug 2015 Equity shares
20 Aug 2014 1.5 Final 22 Aug 2014 Equity shares
19 Jul 2013 1.5 Final 23 Jul 2013 Equity shares
20 Jul 2012 1.5 Final 24 Jul 2012 Equity shares
21 Jul 2011 1.2 Final 23 Jul 2011 Equity shares
23 Sep 2010 1.2 Final 25 Sep 2010 Equity shares
23 Jul 2009 1.2 Final 27 Jul 2009 Equity shares
24 Jul 2008 1.0 Final 26 Jul 2008 Equity shares
20 Jul 2007 1.0 Final 24 Jul 2007 Equity shares
21 Jul 2005 0.0 Final 23 Jul 2005 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

NATURAL CAPSULES LIMITED Share Price

Natural Capsules Limited was incorporated as Public Limited Company established in 1993 at Bangalore. The Company is one of the leading manufacturers of hard capsule shells in India. The Company introduced vegetarian capsules to Indian market and is the second-largest manufacturer of gelatin capsules in the country.

NCL expanded its operations to Puducherry in 2003, further solidifying its position as a trusted brand in the industry. By venturing into API manufacturing under its subsidiary, Natural Biogenex Private Limited, Company presently operates two distinct business verticals-Capsules and APIs. The company is a well-equipped modern manufacturing plant to manufacture Hard Gelatin Capsule shells, Hard Cellulose Capsule shells and Pharmaceutical Dosage Forms in Capsule Dosage Form.

The Company meets the statutory requirements as laid down by the authorities in respect to cGMP and cGLP practices. Since its inception, Natural Capsules has ensured to provide turnkey solutions to all its customers. NCL has evolved and strengthened its endeavors by constantly innovating through its excellent products. With a mission to enable 'Technology Assisted Business Transformation', NCL ensure to deliver the best products with a technological edge.

The main objective of the company is to manufacture and market Hard Gelatin Capsule shells and Hard Cellulose Capsule Shells (both printed and unprinted). These capsules are sold in domestic and also exported to several countries. The logical integration of NCL hard shell manufacturing to formulation was initiated in the year 1998.

The Pharmaceutical and Dietary supplement industries count on Natural Capsules to supply hard two-piece Gelatin and Cellulose capsules. With manufacturing sites at Bangalore and Pondicherry, we are serving customers on quick service no matter where they are located. For the past 12 years, with the greatest respect to the Customers, Natural Capsules has dedicated itself to the production of the highest quality capsules.

During the year 2011-12, the company improvised / modified one of the imported machines and installed it as Pilot plant.

During the year 2015, company commissioned the last machine after modification at Pondicherry plant. With the commissioning of this machine the installed capacity of both units put together has increased to 7.8 Billion capsules per annum.

During the year 2016, company commissioned a pilot machine to manufacture HPMC capsules at Bangalore plant which has a capacity of about 400 million capsules per annum.

In 2021, Company commissioned new generation machines, raising installed capacity to 10.80 billion capsules per annum (BCPA); commissioned new generation machines, raising installed capacity to 14.4 BCPA in 2022.

In 2022-23, Company installed 2 high speed capsule making machine at Bengaluru unit, resulting in increase of installed capacity of the Company from 16.02 billion to 19.5 billion capsules per annum. Further, the installed capacity of the Company stood at 18 billion capsules per annum, with ongoing installation of incremental capacities of HPMC capsules and equipment for API plant in 2023.

In 2024, Company has installed 1 HPMC capsule making machine at Bengaluru unit, resulting in increase of installed capacity of the Company from 16.02 billion to 18.75 billion capsules per annum.

Parent organization Indian Private
NSE symbol NATCAPSUQ
Founded 1993
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Natural Capsules Ltd?

Answer Field

The share price of Natural Capsules Ltd for NSE is ₹ 201 and for BSE is ₹ 204.8.

What is the Market Cap of Natural Capsules Ltd?

Answer Field

The market cap of Natural Capsules Ltd for NSE is ₹ 1,87.91 Cr. and for BSE is ₹ 1,91.46 Cr. as of now.

What is the 52 Week High and Low of Natural Capsules Ltd?

Answer Field

The 52 Week High and Low of Natural Capsules Ltd for NSE is ₹ 269.80 and ₹ 164.00 and for BSE is ₹ 376.90 and ₹ 163.55.

How to Buy Natural Capsules Ltd share?

Answer Field

You can trade in Natural Capsules Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Natural Capsules Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the Current Share Price of Natural Capsules Ltd?

Answer Field

Natural Capsules Ltd share price is for NSE ₹ 201 & for BSE ₹ 204.8 as on Apr 30 2025 03:29 PM.

What is the Market Cap of Natural Capsules Ltd Share?

Answer Field

The market cap of Natural Capsules Ltd for NSE ₹ 1,87.91 & for BSE ₹ 1,91.46 as on Apr 30 2025 03:29 PM.

What is the P/E Ratio of Natural Capsules Ltd Share?

Answer Field

As on Apr 30 2025 03:29 PM the price-to-earnings (PE) ratio for Natural Capsules Ltd share is 36.17.

What is the PB ratio of Natural Capsules Ltd Share?

Answer Field

As on Apr 30 2025 03:29 PM, the price-to-book (PB) ratio for Natural Capsules Ltd share is 158.46.

How to Buy Natural Capsules Ltd Share?

Answer Field

You can trade in Natural Capsules Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Natural Capsules Ltd Share on Bajaj Broking App?

Answer Field

To buy Natural Capsules Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Natural Capsules Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|